Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction

Xylem Inc. (NYSE: XYL), a leading global water technology company (“Xylem”), and Evoqua (NYSE: AQUA), a leader in mission-critical water treatment solutions and services, today announced they have entered into a definitive agreement under which Xylem will acquire Evoqua in an all-stock transaction that reflects an implied enterprise value of approximately $7.5 billion.

As water risks rise in global importance, this transaction unites two companies with a shared focus on solving the world’s water challenges by addressing customers’ and communities’ most critical needs. Building on Xylem’s global leadership in water solutions and Evoqua’s leadership in advanced treatment solutions and services, the combined company will be uniquely positioned to develop and deliver an even more comprehensive offering of innovative solutions.

Evoqua, a leader in North America water treatment, complements Xylem’s distinctive portfolio of solutions with advanced water and wastewater treatment capabilities, a powerful and extensive network of service professionals and access to a number of attractive industrial markets with resilient, recurring revenue streams. Evoqua’s solutions, including digitally enabled offerings, optimize and outsource mission-critical water treatment systems for customers in high-growth sectors such as life sciences, microelectronics, power and food and beverage. In addition, Evoqua is a leader in the remediation of emerging contaminants, including PFAS.

Xylem and Evoqua generated over $7 billion in combined revenue in the 12-month period ending September 30, 2022, with $1.2 billion in adjusted EBITDA. The combination unlocks compelling new growth opportunities and is expected to deliver run-rate cost synergies of $140 million within three years, driven by scale efficiencies in procurement, network optimization and corporate costs. In addition, the transaction allows Xylem to maintain its strong balance sheet, which provides the combined company with significant strategic flexibility and optionality.

"Solving the world’s water challenges has never been more urgent. Our acquisition of Evoqua creates a transformative global platform to address water scarcity, affordability and resilience at even greater scale,” said Patrick Decker, President and CEO of Xylem.

The combined company delivers an unparalleled portfolio of advanced technologies, integrated services and application expertise across the water cycle.

Patrick Decker, President and CEO, Xylem

Together, our complementary businesses will be even more strongly positioned to help our customers and communities tackle their most challenging water needs,” continued Decker. “We are excited about building the world’s most powerful platform for solving water alongside our Evoqua colleagues.”

“Joining forces with Xylem is an exciting opportunity for Evoqua and for our team members. This combination provides a platform to leverage our combined strengths and increase our impact to better address the most pressing and increasingly complex global water challenges,” said Ron Keating, Evoqua's President and CEO.

I am incredibly proud of what our team at Evoqua has achieved to date, providing mission-critical water treatment solutions to the market and for our customers. Along the way, we have earned a reputation for quality, safety and reliability around the world. Together with Xylem, we will drive innovation on a larger scale for our customers, positioning us to create even more value for our stakeholders.

Ron Keating, President and CEO, Evoqua

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Xylem Analytics. (2023, January 25). Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction. AZoLifeSciences. Retrieved on November 24, 2024 from https://www.azolifesciences.com/news/20230125/Xylem-To-Acquire-Evoqua-in-2475-Billion-All-Stock-Transaction.aspx.

  • MLA

    Xylem Analytics. "Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction". AZoLifeSciences. 24 November 2024. <https://www.azolifesciences.com/news/20230125/Xylem-To-Acquire-Evoqua-in-2475-Billion-All-Stock-Transaction.aspx>.

  • Chicago

    Xylem Analytics. "Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction". AZoLifeSciences. https://www.azolifesciences.com/news/20230125/Xylem-To-Acquire-Evoqua-in-2475-Billion-All-Stock-Transaction.aspx. (accessed November 24, 2024).

  • Harvard

    Xylem Analytics. 2023. Xylem To Acquire Evoqua in $7.5 Billion All-Stock Transaction. AZoLifeSciences, viewed 24 November 2024, https://www.azolifesciences.com/news/20230125/Xylem-To-Acquire-Evoqua-in-2475-Billion-All-Stock-Transaction.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.